osteoarthritis
Preliminary        data suggest that celecoxib, a highly selective COX-2 inhibitor, is superior to       placebo and similar to traditional NSAIDs in the short-term treatment of pain due       to osteoarthritis, although it has been associated with adverse effects such as       headache, change in bowel habits, abdominal discomfort, and dizziness.
Preliminary        data suggest that celecoxib, a highly selective COX-2 inhibitor, is superior to       placebo and similar to traditional NSAIDs in the short-term treatment of  @OBJECT$   @PREDICAT$   @SUBJECT$ , although it has been associated with adverse effects such as       headache, change in bowel habits, abdominal discomfort, and dizziness.